An Open Label, Balanced, Randomized, Two Treatments, Three Sequences, Three Periods, Single Dose, Semi-Replicate, Crossover, Oral Bioequivalence Study of Palbociclib 125 Mg Capsules of Abbott Laboratories De Colombia Versus Ibrance (Palbociclib) 125 Mg Capsules of Pfizer in Healthy, Adult, Human Subjects Under Fed Conditions
completed the study were analyzed to determine the plasma concentration of Palbociclib using bio-analytical method. The ISCV of reference product for Cmax is 11.21% and the 90% confidence interval

